Cargando…

What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy

BACKGROUND: We performed a dosimetric comparison of spot-scanning proton therapy (SSPT) and intensity-modulated radiation therapy (IMRT) for hepatocellular carcinoma (HCC) to investigate the impact of tumor size on the risk of radiation induced liver disease (RILD). METHODS: A number of alternative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toramatsu, Chie, Katoh, Norio, Shimizu, Shinichi, Nihongi, Hideaki, Matsuura, Taeko, Takao, Seishin, Miyamoto, Naoki, Suzuki, Ryusuke, Sutherland, Kenneth, Kinoshita, Rumiko, Onimaru, Rikiya, Ishikawa, Masayori, Umegaki, Kikuo, Shirato, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606425/ https://www.ncbi.nlm.nih.gov/pubmed/23497543 http://dx.doi.org/10.1186/1748-717X-8-48

Ejemplares similares

A motion-compensated image filter for low-dose fluoroscopy in a real-time tumor-tracking radiotherapy system
por: Miyamoto, Naoki, et al.
Publicado: (2015)

Validation of dose distribution for liver tumors treated with real-time-image gated spot-scanning proton therapy by log data based dose reconstruction
por: Yamada, Takahiro, et al.
Publicado: (2021)

A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate
por: Fujii, Yusuke, et al.
Publicado: (2017)

Potential benefits of adaptive intensity‐modulated proton therapy in nasopharyngeal carcinomas
por: Minatogawa, Hideki, et al.
Publicado: (2020)

Physical and biological impacts of collimator‐scattered protons in spot‐scanning proton therapy
por: Ueno, Koki, et al.
Publicado: (2019)

Dynamic gating window technique for the reduction of dosimetric error in respiratory‐gated spot‐scanning particle therapy: An initial phantom study using patient tumor trajectory data
por: Miyamoto, Naoki, et al.
Publicado: (2020)

Prediction of target position from multiple fiducial markers by partial least squares regression in real-time tumor-tracking radiation therapy
por: Ukon, Kanako, et al.
Publicado: (2021)

Analysis of treatment process time for real‐time‐image gated‐spot‐scanning proton‐beam therapy (RGPT) system
por: Yoshimura, Takaaki, et al.
Publicado: (2019)

A Literature Review of Proton Beam Therapy for Prostate Cancer in Japan
por: Hoshina, Rika Maglente, et al.
Publicado: (2019)

Quantitative analysis of treatments using real‐time image gated spot‐scanning with synchrotron‐based proton beam therapy system log data
por: Yoshimura, Takaaki, et al.
Publicado: (2020)

A Proton Beam Therapy System Dedicated to Spot-Scanning Increases Accuracy with Moving Tumors by Real-Time Imaging and Gating and Reduces Equipment Size
por: Shimizu, Shinichi, et al.
Publicado: (2014)

Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults
por: Hashimoto, Takayuki, et al.
Publicado: (2019)

Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system
por: Nishioka, Kentaro, et al.
Publicado: (2018)

Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system
por: Shimizu, Shinichi, et al.
Publicado: (2014)

Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy
por: Kobashi, Keiji, et al.
Publicado: (2018)

Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients
por: Yasuda, Koichi, et al.
Publicado: (2020)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
por: Inoue, Tetsuya, et al.
Publicado: (2012)

On-line range verification for proton beam therapy using spherical ionoacoustic waves with resonant frequency
por: Takayanagi, Taisuke, et al.
Publicado: (2020)

Are simple verbal instructions sufficient to ensure that bladder volume does not deteriorate prostate position reproducibility during spot scanning proton therapy?
por: Nishioka, Kentaro, et al.
Publicado: (2021)

A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity
por: Uchinami, Yusuke, et al.
Publicado: (2022)

Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0702)
por: Nishio, Teiji, et al.
Publicado: (2014)

A novel range-verification method using ionoacoustic wave generated from spherical gold markers for particle-beam therapy: a simulation study
por: Takayanagi, Taisuke, et al.
Publicado: (2019)

Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
por: Hirayama, Shusuke, et al.
Publicado: (2020)

Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients
por: Tamura, Masaya, et al.
Publicado: (2017)

Development of a wavelength-separated type scintillator with optical fiber (SOF) dosimeter to compensate for the Cerenkov radiation effect
por: Ishikawa, Masayori, et al.
Publicado: (2015)

A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam
por: Maeda, Kenichiro, et al.
Publicado: (2016)

Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer
por: Inoue, Tetsuya, et al.
Publicado: (2013)

Evaluation of the dosimetric effect of scattered protons in clinical practice in passive scattering proton therapy
por: Kim, Chankyu, et al.
Publicado: (2021)

A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer
por: Yoshimura, Takaaki, et al.
Publicado: (2021)

Dosimetric impact of range uncertainty in passive scattering proton therapy
por: Liu, Ruirui, et al.
Publicado: (2021)

Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers
por: Nishioka, Kentaro, et al.
Publicado: (2017)

Impact of organ motion on volumetric and dosimetric parameters in stomach lymphomas treated with intensity‐modulated radiotherapy
por: Uchinami, Yusuke, et al.
Publicado: (2019)

Dosimetric Application of Phosphorus Doped Fibre for X-ray and Proton Therapy
por: Olusoji, Olugbenga J., et al.
Publicado: (2021)

Dosimetric Advantages of Silicone-Filled Vaginal Spacers in Pediatric Proton Therapy
por: Ates, Ozgur, et al.
Publicado: (2022)

Dosimetric Effects of the Supine and Prone Positions in Proton Therapy for Prostate Cancer
por: Kato, Takahiro, et al.
Publicado: (2022)

Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy
por: Lee, Howard, et al.
Publicado: (2017)

A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy
por: Rah, Jeong-Eun, et al.
Publicado: (2016)

Dosimetric Effect of Biozorb Markers for Accelerated Partial Breast Irradiation in Proton Therapy
por: Parham, Melton D., et al.
Publicado: (2021)

Dosimetric Results for Adjuvant Proton Radiation Therapy of HPV-Associated Oropharynx Cancer
por: Wright, Christopher M., et al.
Publicado: (2021)

Dosimetric impact of adaptive proton therapy in head and neck cancer – A review
por: Huiskes, Merle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_evslbqcq3ubo2fh9b8utnc8jqb